Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Oncolytics Biotech, Inc. (ONCY)

NASDAQ

$0.79

$-0.01

(-1.13%)

Pre-Market

Oncolytics Biotech, Inc. (ONCY) Live Price Chart

Last updated: ⁦2026-09-16 10:32:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Oncolytics Biotech, Inc. (ONCY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.79, with a market capitalisation of $103.63M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.73 to $1.51. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$103.63M
Open	$0.80
Day's High	$9.84
Day's Low	$0.24
Previous Close	$0.78
Volume	158.00
Average Volume	1.12M
P/E Ratio	--
52-Week High	$1.51
52-Week Low	$0.73
Dividend Yield	4.65%
Earnings Date	--

Oncolytics Biotech, Inc. (ONCY) Pre-Market Stock Price

Oncolytics Biotech, Inc. (ONCY) is trading at $0.79 in pre-market trading as of 2026-09-16 10:00:00, up 0.77% ($0.01) from the previous close of $0.78

Pre-market trading shows how investors are pricing ONCY before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Oncolytics Biotech, Inc. (ONCY) 7-Day Stock Price Change

Over the past seven days, Oncolytics Biotech, Inc. (ONCY) moved from $0.84 to $0.79, representing a decline of 6.78% ($0.06).

The stock traded between $0.73 and $0.85 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 1.38 million shares, up versus the previous seven-day period, indicating higher trading activity.

ONCY 52-Week Price Position

Position in Range: 7.2%

52W Low$0.73

52W High$1.51

ONCY is currently trading at $0.79, placing it 7.2% of the way from its 52-week low of $0.73 to its 52-week high of $1.51. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Oncolytics Biotech, Inc. (ONCY)?

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Oncolytics Biotech, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	29
Exchange	NASDAQ
Company Website	https://www.oncolyticsbiotech.com

How to Buy Oncolytics Biotech, Inc. (ONCY) Stock on MEXC

Eligible investors can buy real shares of Oncolytics Biotech, Inc. (ONCY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ONCY and Place Your Order

Open the RealStocks trading page and search for ONCY. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Oncolytics Biotech, Inc. (ONCY) stock price today?

Oncolytics Biotech, Inc. (ONCY) is currently trading at $ 0.79, up 0.77% ($0.01) from the previous close of $ 0.78. Intraday prices update in real time during regular trading hours.

2.Is ONCY stock going up or down today?

As of 2026-09-16 10:00:00, ONCY is trading at $ 0.79, up 0.77% ($0.01) from its previous close of $ 0.78. The stock has traded between $ 0.24 and $ 9.84 during today’s regular session. Past price movements do not guarantee future results.

3.What is ONCY pre-market price?

As of 2026-09-16 10:00:00, ONCY is trading at $ 0.79 in pre-market trading, up 0.77% ($0.01) from the previous close of $ 0.78. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ONCY after-hours price?

As of 2026-09-16 10:00:00, ONCY is trading at $ 0.80 in after-hours trading, up 2.05% ($0.02) from the regular-session close of $ 0.78. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ONCY stock trading now?

ONCY trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ONCY sit relative to its 52-week high and low?

Over the past 52 weeks, ONCY has traded between a low of $ 0.73 and a high of $ 1.51. At $ 0.79, the stock is positioned 7.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Oncolytics Biotech, Inc. in?

Oncolytics Biotech, Inc. (ONCY) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Oncolytics Biotech, Inc.'s market capitalisation and where is it listed?

Oncolytics Biotech, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 103.63M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ONCY valued in terms of P/E ratio and EPS?

ONCY trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.11. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Oncolytics Biotech, Inc. pay a dividend?

Oncolytics Biotech, Inc. pays an indicated annual cash dividend of $ 0.04 per share, with a current dividend yield of 4.65% based on the latest share price. Dividend policies are subject to change at the board's discretion.